Psilocybin therapy for severe alcohol use disorder
Treatments studied
Part of Mental health clinical trials.
This trial tests whether a single dose of psilocybin (the active ingredient in 'magic mushrooms') combined with therapy can help people with severe alcohol use disorder reduce or stop drinking. It's for people who've recently completed detox and are ready to commit to a structured program in Boston.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old and speak English.
- You have been diagnosed with severe alcohol use disorder and completed detox in the last 3 months.
- You can attend all study visits and therapy sessions in Boston, and have someone to bring you home after psilocybin sessions.
- You do not have a personal or family history of psychotic disorders (like schizophrenia) or bipolar disorder.
- You are not at high risk for suicide or currently using certain other drugs (like opioids or cocaine) as a major problem.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a psilocybin (magic mushroom) therapy session can help people with alcohol use disorder reduce their drinking. You'll have one or two guided sessions with a therapist, plus support before and after, to see if it helps you change your drinking habits.
This trial tests whether psilocybin (the active ingredient in magic mushrooms), given with talk therapy, can help people who want to reduce their heavy drinking. It is for people with at least moderate alcohol use disorder who are motivated to change.
This study tests whether psilocybin, a psychedelic drug, combined with therapy can help people reduce or stop drinking. It aims to understand how psilocybin affects the brain and behavior in people with alcohol use disorder.
This study tests whether psilocybin (a psychedelic compound) can help people with severe alcohol use disorder stay sober longer, especially if they also have depression. Participants receive guided psilocybin sessions alongside counseling to reduce the risk of returning to heavy drinking.
This trial tests two psychedelic-assisted therapies, psilocybin and ketamine, to see which works better for reducing heavy drinking in people with alcohol use disorder (AUD). You'll receive either drug along with counseling, and the study monitors safety closely.
This trial tests if psilocybin, a substance found in certain mushrooms, can help people with various mental health symptoms that affect daily life. You would take a single dose in a supervised setting and be monitored for changes in your mood and well-being.
Hear when a new Alcohol Use Disorder trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.